Early gastrointestinal cancer and elevated lesions
Conditions
Interventions
Group P:Receive 1.5 - 2 mg/kg of propofol for anesthesia induction
Group R:Receive 0.3 mg/kg of tropisetron hydrochloride for anesthesia induction
Group PR:Received 1mg/kg propofol + 0.2mg/kg remifentanil for anesthesia induction
Sponsors
Mianyang 404 Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and less than 65 years old, gender not restricted; 2. ASA score is level I or II; 3. BMI between 18 kg/m^2 and 30 kg/m^2; 4. Clearly understand and voluntarily participate in this study, and sign the informed consent form by oneself.
Exclusion criteria
Exclusion criteria: 1. Including severe liver or kidney dysfunction, cardiovascular diseases (such as acute or decompensated heart failure, acute coronary syndrome, third-degree atrioventricular block or severe heart valve disease); 2. Brain diseases, mental disorders; 3. Allergy to the drugs involved in this study (such as benzodiazepines, propofol, opioids, flumazenil or naloxone); patients judged to have difficulty in airway management or those who refuse to participate in this study for any reason; 4. Patients with contraindications for EUS; 5. Pregnant women; 6. Patients planning to undergo therapeutic EUS surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of low SPO2; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anesthesia induction time;Anesthesia recovery time;Time from discontinuation of anesthetic agents to an Aldrete Score = 9; | — |
Countries
China
Contacts
Public ContactWen Xu
Mianyang 404 Hospital
Outcome results
None listed